Rank | Gene Set | Z-score |
---|---|---|
1 | motile cilium assembly (GO:0044458) | 9.61868515 |
2 | cilium movement (GO:0003341) | 9.53024009 |
3 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 8.44579251 |
4 | epithelial cilium movement (GO:0003351) | 7.87468251 |
5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.94945482 |
6 | endocrine pancreas development (GO:0031018) | 6.90176983 |
7 | primary alcohol catabolic process (GO:0034310) | 6.75888352 |
8 | axoneme assembly (GO:0035082) | 6.38724926 |
9 | ethanol metabolic process (GO:0006067) | 6.33875057 |
10 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 6.14976027 |
11 | protein maturation by protein folding (GO:0022417) | 6.01747152 |
12 | protein retention in ER lumen (GO:0006621) | 5.99405036 |
13 | peptide hormone processing (GO:0016486) | 5.93429628 |
14 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.91207594 |
15 | COPII vesicle coating (GO:0048208) | 5.86853835 |
16 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.82977981 |
17 | glandular epithelial cell differentiation (GO:0002067) | 5.71949286 |
18 | left/right pattern formation (GO:0060972) | 5.58686781 |
19 | desmosome organization (GO:0002934) | 5.56152258 |
20 | one-carbon compound transport (GO:0019755) | 5.52795939 |
21 | ethanol oxidation (GO:0006069) | 5.49550932 |
22 | type B pancreatic cell development (GO:0003323) | 5.32121243 |
23 | signal peptide processing (GO:0006465) | 5.30647329 |
24 | diterpenoid biosynthetic process (GO:0016102) | 5.28019023 |
25 | vitamin transmembrane transport (GO:0035461) | 5.16318308 |
26 | * multicellular organismal water homeostasis (GO:0050891) | 5.11100339 |
27 | exocrine pancreas development (GO:0031017) | 5.11064279 |
28 | sequestering of metal ion (GO:0051238) | 5.08978881 |
29 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.06331960 |
30 | glandular epithelial cell development (GO:0002068) | 5.02731322 |
31 | gonadal mesoderm development (GO:0007506) | 4.84279563 |
32 | positive regulation of nuclease activity (GO:0032075) | 4.79366349 |
33 | insulin secretion (GO:0030073) | 4.66836129 |
34 | sperm capacitation (GO:0048240) | 4.66186632 |
35 | keratinization (GO:0031424) | 4.64386598 |
36 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.62945977 |
37 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.62088212 |
38 | oligosaccharide biosynthetic process (GO:0009312) | 4.56601841 |
39 | vesicle coating (GO:0006901) | 4.50557101 |
40 | ER overload response (GO:0006983) | 4.48387200 |
41 | establishment of skin barrier (GO:0061436) | 4.46474274 |
42 | regulation of water loss via skin (GO:0033561) | 4.40294599 |
43 | O-glycan processing (GO:0016266) | 4.39636710 |
44 | negative regulation of humoral immune response (GO:0002921) | 4.34036506 |
45 | regulation of nuclease activity (GO:0032069) | 4.33940902 |
46 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.29616875 |
47 | positive regulation of insulin secretion (GO:0032024) | 4.28872957 |
48 | * water homeostasis (GO:0030104) | 4.27024716 |
49 | toxin metabolic process (GO:0009404) | 4.21602309 |
50 | nitric oxide mediated signal transduction (GO:0007263) | 4.21310053 |
51 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.21120070 |
52 | cellular response to unfolded protein (GO:0034620) | 4.19214216 |
53 | lung epithelium development (GO:0060428) | 4.14535177 |
54 | cellular response to vitamin D (GO:0071305) | 4.13693418 |
55 | columnar/cuboidal epithelial cell development (GO:0002066) | 4.12180417 |
56 | establishment of tissue polarity (GO:0007164) | 4.05981251 |
57 | establishment of planar polarity (GO:0001736) | 4.05981251 |
58 | cellular response to topologically incorrect protein (GO:0035967) | 4.04906857 |
59 | regulation of insulin secretion (GO:0050796) | 4.04165498 |
60 | ER-nucleus signaling pathway (GO:0006984) | 4.01473621 |
61 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.99685181 |
62 | detection of calcium ion (GO:0005513) | 3.98323968 |
63 | left/right axis specification (GO:0070986) | 3.98048749 |
64 | thyroid hormone generation (GO:0006590) | 3.94847632 |
65 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.88980759 |
66 | surfactant homeostasis (GO:0043129) | 3.84010766 |
67 | regulation of cilium movement (GO:0003352) | 3.81532985 |
68 | microtubule bundle formation (GO:0001578) | 3.71527544 |
69 | regulation of interleukin-13 production (GO:0032656) | 3.70913517 |
70 | negative regulation of norepinephrine secretion (GO:0010700) | 3.70297130 |
71 | regulation of peptide hormone secretion (GO:0090276) | 3.68168486 |
72 | retinoic acid metabolic process (GO:0042573) | 3.67981873 |
73 | ventricular system development (GO:0021591) | 3.65068364 |
74 | regulation of peptide secretion (GO:0002791) | 3.61215521 |
75 | establishment of apical/basal cell polarity (GO:0035089) | 3.60734937 |
76 | regulation of interleukin-5 production (GO:0032674) | 3.59208195 |
77 | peptide hormone secretion (GO:0030072) | 3.58851136 |
78 | negative regulation of bone resorption (GO:0045779) | 3.58806157 |
79 | primary alcohol metabolic process (GO:0034308) | 3.57677794 |
80 | negative regulation of insulin secretion (GO:0046676) | 3.56063219 |
81 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.56018353 |
82 | peptide secretion (GO:0002790) | 3.50783551 |
83 | response to endoplasmic reticulum stress (GO:0034976) | 3.49348556 |
84 | positive regulation of peptide hormone secretion (GO:0090277) | 3.47177545 |
85 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.44639389 |
86 | terpenoid biosynthetic process (GO:0016114) | 3.43602765 |
87 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.43407712 |
88 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.41237970 |
89 | positive regulation of peptide secretion (GO:0002793) | 3.34527589 |
90 | retinol metabolic process (GO:0042572) | 3.33927066 |
91 | peptide catabolic process (GO:0043171) | 3.32755871 |
92 | cellular zinc ion homeostasis (GO:0006882) | 3.31919343 |
93 | glutathione biosynthetic process (GO:0006750) | 3.31528573 |
94 | negative regulation of catecholamine secretion (GO:0033604) | 3.29156899 |
95 | renal absorption (GO:0070293) | 3.28097064 |
96 | hormone catabolic process (GO:0042447) | 3.28044478 |
97 | response to unfolded protein (GO:0006986) | 3.27559331 |
98 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.27300242 |
99 | polyol transport (GO:0015791) | 3.27079709 |
100 | induction of positive chemotaxis (GO:0050930) | 3.24348912 |
101 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.24202060 |
102 | peptidyl-asparagine modification (GO:0018196) | 3.21848360 |
103 | response to hexose (GO:0009746) | 3.19173976 |
104 | negative regulation of B cell mediated immunity (GO:0002713) | 3.17018000 |
105 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.17018000 |
106 | response to topologically incorrect protein (GO:0035966) | 3.16583511 |
107 | regulation of hormone secretion (GO:0046883) | 3.15254858 |
108 | apoptotic cell clearance (GO:0043277) | 3.14835298 |
109 | positive regulation of glycolytic process (GO:0045821) | 3.13768383 |
110 | macroautophagy (GO:0016236) | 3.13286343 |
111 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.11139065 |
112 | response to glucose (GO:0009749) | 3.09610144 |
113 | negative regulation of peptide hormone secretion (GO:0090278) | 3.06671458 |
114 | thyroid hormone metabolic process (GO:0042403) | 3.05898005 |
115 | response to monosaccharide (GO:0034284) | 3.05721519 |
116 | apical protein localization (GO:0045176) | 3.05235946 |
117 | nucleoside diphosphate catabolic process (GO:0009134) | 3.04880441 |
118 | epithelial cell fate commitment (GO:0072148) | 3.03911159 |
119 | intestinal epithelial cell development (GO:0060576) | 3.03452107 |
120 | * excretion (GO:0007588) | 3.03363813 |
121 | glomerular epithelial cell development (GO:0072310) | 3.03181596 |
122 | regulation of autophagic vacuole assembly (GO:2000785) | 3.02792368 |
123 | peptide cross-linking (GO:0018149) | 3.02551915 |
124 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.01768254 |
125 | protein localization to Golgi apparatus (GO:0034067) | 3.00714965 |
126 | tolerance induction (GO:0002507) | 3.00642988 |
127 | protein N-linked glycosylation (GO:0006487) | 2.98035486 |
128 | lipoxygenase pathway (GO:0019372) | 2.97564205 |
129 | cellular response to vitamin (GO:0071295) | 2.97213677 |
130 | regulation of peptide transport (GO:0090087) | 2.96851936 |
131 | response to xenobiotic stimulus (GO:0009410) | 2.96191461 |
132 | negative regulation of peptide secretion (GO:0002792) | 2.96170730 |
133 | cellular response to antibiotic (GO:0071236) | 2.94866658 |
134 | keratinocyte differentiation (GO:0030216) | 2.94392737 |
135 | intraciliary transport (GO:0042073) | 2.93067847 |
136 | Golgi organization (GO:0007030) | 2.92339333 |
137 | regulation of germinal center formation (GO:0002634) | 2.90640395 |
138 | astrocyte differentiation (GO:0048708) | 2.88771044 |
139 | protein O-linked glycosylation (GO:0006493) | 2.88205531 |
140 | peptide transport (GO:0015833) | 2.86457459 |
141 | amyloid precursor protein catabolic process (GO:0042987) | 2.86163849 |
142 | establishment of monopolar cell polarity (GO:0061162) | 2.84874114 |
143 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.84874114 |
144 | negative regulation of bone remodeling (GO:0046851) | 2.84554548 |
145 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.84175113 |
146 | cellular response to glucagon stimulus (GO:0071377) | 2.83970945 |
147 | hypotonic response (GO:0006971) | 2.83659595 |
148 | hormone secretion (GO:0046879) | 2.83409279 |
149 | progesterone metabolic process (GO:0042448) | 2.80590138 |
150 | cilium organization (GO:0044782) | 2.79922667 |
151 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.79898186 |
152 | ear development (GO:0043583) | 2.79877966 |
153 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.79863399 |
154 | glucose homeostasis (GO:0042593) | 2.79680611 |
155 | carbohydrate homeostasis (GO:0033500) | 2.79680611 |
156 | chemical homeostasis within a tissue (GO:0048875) | 2.78656325 |
157 | pancreas development (GO:0031016) | 2.77690172 |
158 | glutathione derivative biosynthetic process (GO:1901687) | 2.77632618 |
159 | glutathione derivative metabolic process (GO:1901685) | 2.77632618 |
160 | regulation of oxidative phosphorylation (GO:0002082) | 2.76762583 |
161 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.76431756 |
162 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.76311011 |
163 | regulation of energy homeostasis (GO:2000505) | 2.75653884 |
164 | negative regulation of inclusion body assembly (GO:0090084) | 2.75042261 |
165 | positive regulation of hormone secretion (GO:0046887) | 2.74282134 |
166 | glomerular filtration (GO:0003094) | 2.73424557 |
167 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.73239270 |
168 | response to hepatocyte growth factor (GO:0035728) | 2.73239270 |
169 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.72805460 |
170 | cellular response to hexose stimulus (GO:0071331) | 2.72226645 |
171 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.71616560 |
172 | Golgi vesicle transport (GO:0048193) | 2.71212793 |
173 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.69175189 |
174 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.69175189 |
175 | intestinal absorption (GO:0050892) | 2.68148581 |
176 | cilium assembly (GO:0042384) | 2.67826309 |
177 | keratinocyte proliferation (GO:0043616) | 2.66237214 |
178 | positive regulation of tolerance induction (GO:0002645) | 2.64351341 |
179 | regulation of vacuole organization (GO:0044088) | 2.60870177 |
180 | renal filtration (GO:0097205) | 2.60357805 |
181 | epithelial cell-cell adhesion (GO:0090136) | 2.59866320 |
182 | * sodium ion homeostasis (GO:0055078) | 2.56458050 |
183 | iron ion import (GO:0097286) | 2.56226641 |
184 | carnitine metabolic process (GO:0009437) | 2.54162369 |
185 | epidermis development (GO:0008544) | 2.53500376 |
186 | glutathione metabolic process (GO:0006749) | 2.52318906 |
187 | epidermal cell differentiation (GO:0009913) | 2.51439021 |
188 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.50307430 |
189 | regulation of response to osmotic stress (GO:0047484) | 2.48256570 |
190 | positive regulation of p38MAPK cascade (GO:1900745) | 2.47779676 |
191 | sialylation (GO:0097503) | 2.46939380 |
192 | axonemal dynein complex assembly (GO:0070286) | 13.9169995 |
193 | cilium or flagellum-dependent cell motility (GO:0001539) | 11.8409239 |
194 | Golgi transport vesicle coating (GO:0048200) | 10.4727358 |
195 | COPI coating of Golgi vesicle (GO:0048205) | 10.4727358 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 8.39818074 |
2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.65817694 |
3 | GATA1_22025678_ChIP-Seq_K562_Human | 4.56355256 |
4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.47131135 |
5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.11250808 |
6 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 3.22121311 |
7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.63428187 |
8 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.54354231 |
9 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.52457476 |
10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.51761689 |
11 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.31320230 |
12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.10069291 |
13 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.03927235 |
14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.94244717 |
15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.91096957 |
16 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.89457096 |
17 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.87762514 |
18 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.85372385 |
19 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.78999126 |
20 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.69647247 |
21 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.69221238 |
22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68519755 |
23 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.63971267 |
24 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.62632551 |
25 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.62149170 |
26 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.59838480 |
27 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.59364759 |
28 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56444060 |
29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54085517 |
30 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.53075013 |
31 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.52661146 |
32 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.50887075 |
33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.50880076 |
34 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.49854915 |
35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.47854303 |
36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47554592 |
37 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.47058603 |
38 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44348427 |
39 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.41442223 |
40 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.37542476 |
41 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.37394239 |
42 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.35394650 |
43 | GATA1_19941826_ChIP-Seq_K562_Human | 1.35111462 |
44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33321699 |
45 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.30401286 |
46 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.25505426 |
47 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.24339268 |
48 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.21736435 |
49 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20749651 |
50 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20298654 |
51 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.19998970 |
52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19698131 |
53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19682896 |
54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19181145 |
55 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18591742 |
56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18057744 |
57 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.16792029 |
58 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16590652 |
59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16416604 |
60 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15891885 |
61 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.14775689 |
62 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.14775689 |
63 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.14499079 |
64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12923548 |
65 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12850379 |
66 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10897638 |
67 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10897638 |
68 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.08937486 |
69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08903050 |
70 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08454809 |
71 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.07637039 |
72 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.07525940 |
73 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05574010 |
74 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04687571 |
75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04523818 |
76 | * P68_20966046_ChIP-Seq_HELA_Human | 1.04035291 |
77 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.03316547 |
78 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03166564 |
79 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02281224 |
80 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00974691 |
81 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.00150626 |
82 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00111311 |
83 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99717577 |
84 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98265350 |
85 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97964658 |
86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97721680 |
87 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.97492221 |
88 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96460754 |
89 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96240576 |
90 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95562198 |
91 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.95453541 |
92 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94934890 |
93 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94381163 |
94 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94105884 |
95 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94067463 |
96 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.93590338 |
97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92335695 |
98 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91966919 |
99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91873477 |
100 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.91199367 |
101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90366527 |
102 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90104778 |
103 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88746613 |
104 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88087952 |
105 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.87535864 |
106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87209576 |
107 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86546312 |
108 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86142818 |
109 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86004899 |
110 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.85447480 |
111 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.84752659 |
112 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.84371759 |
113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83867736 |
114 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.83791337 |
115 | SA1_27219007_Chip-Seq_Bcells_Human | 0.83534650 |
116 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.83500695 |
117 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.83383707 |
118 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.82432945 |
119 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.81726224 |
120 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81662690 |
121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81188520 |
122 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.81001952 |
123 | KDM2B_26808549_Chip-Seq_K562_Human | 0.80923092 |
124 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.80169392 |
125 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80005461 |
126 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.79535893 |
127 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.78908998 |
128 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78871657 |
129 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.78333036 |
130 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78291869 |
131 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78286300 |
132 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.76881863 |
133 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.76713971 |
134 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.75437866 |
135 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.74947885 |
136 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.74771326 |
137 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74634557 |
138 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.74164965 |
139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.74110013 |
140 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.73692578 |
141 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.73624156 |
142 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.73375487 |
143 | STAT3_23295773_ChIP-Seq_U87_Human | 0.73068434 |
144 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.72594298 |
145 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.72588017 |
146 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.72328094 |
147 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.71999846 |
148 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.71722319 |
149 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.71441126 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002877_abnormal_melanocyte_morpholog | 5.57574197 |
2 | MP0003283_abnormal_digestive_organ | 5.25864962 |
3 | MP0002796_impaired_skin_barrier | 4.33556133 |
4 | MP0009780_abnormal_chondrocyte_physiolo | 4.05871201 |
5 | MP0002693_abnormal_pancreas_physiology | 3.89753587 |
6 | MP0010386_abnormal_urinary_bladder | 3.88533617 |
7 | MP0002909_abnormal_adrenal_gland | 3.83104077 |
8 | * MP0004043_abnormal_pH_regulation | 3.82141693 |
9 | MP0000013_abnormal_adipose_tissue | 3.78157798 |
10 | MP0000678_abnormal_parathyroid_gland | 3.77729373 |
11 | MP0001944_abnormal_pancreas_morphology | 3.59920517 |
12 | MP0003195_calcinosis | 3.58399315 |
13 | MP0000566_synostosis | 3.35376931 |
14 | MP0003183_abnormal_peptide_metabolism | 3.04998041 |
15 | MP0005220_abnormal_exocrine_pancreas | 2.95579464 |
16 | MP0010678_abnormal_skin_adnexa | 2.87882265 |
17 | MP0005379_endocrine/exocrine_gland_phen | 2.80971152 |
18 | MP0004264_abnormal_extraembryonic_tissu | 2.49851407 |
19 | MP0002132_abnormal_respiratory_system | 2.47926636 |
20 | MP0002653_abnormal_ependyma_morphology | 2.42649685 |
21 | MP0003453_abnormal_keratinocyte_physiol | 2.34585484 |
22 | MP0005501_abnormal_skin_physiology | 2.26266592 |
23 | MP0000383_abnormal_hair_follicle | 2.25195046 |
24 | MP0000003_abnormal_adipose_tissue | 2.19509764 |
25 | MP0005275_abnormal_skin_tensile | 2.15953210 |
26 | MP0003300_gastrointestinal_ulcer | 2.12322815 |
27 | MP0002078_abnormal_glucose_homeostasis | 2.11177629 |
28 | MP0002837_dystrophic_cardiac_calcinosis | 2.05151127 |
29 | MP0002138_abnormal_hepatobiliary_system | 2.04310107 |
30 | MP0009379_abnormal_foot_pigmentation | 1.98281128 |
31 | * MP0001765_abnormal_ion_homeostasis | 1.95502867 |
32 | MP0000462_abnormal_digestive_system | 1.95007849 |
33 | * MP0009643_abnormal_urine_homeostasis | 1.94789797 |
34 | MP0010352_gastrointestinal_tract_polyps | 1.90100923 |
35 | MP0005645_abnormal_hypothalamus_physiol | 1.88329785 |
36 | MP0002638_abnormal_pupillary_reflex | 1.84702022 |
37 | MP0010155_abnormal_intestine_physiology | 1.81130716 |
38 | MP0000465_gastrointestinal_hemorrhage | 1.78241424 |
39 | MP0003303_peritoneal_inflammation | 1.76830189 |
40 | MP0000681_abnormal_thyroid_gland | 1.73164696 |
41 | MP0004782_abnormal_surfactant_physiolog | 1.72651266 |
42 | MP0002896_abnormal_bone_mineralization | 1.72017829 |
43 | MP0001756_abnormal_urination | 1.69142130 |
44 | MP0006072_abnormal_retinal_apoptosis | 1.68107185 |
45 | MP0002277_abnormal_respiratory_mucosa | 1.64069636 |
46 | MP0005058_abnormal_lysosome_morphology | 1.63607595 |
47 | MP0001216_abnormal_epidermal_layer | 1.59546881 |
48 | MP0000467_abnormal_esophagus_morphology | 1.58208302 |
49 | MP0006054_spinal_hemorrhage | 1.56754277 |
50 | MP0003191_abnormal_cellular_cholesterol | 1.56368177 |
51 | MP0000613_abnormal_salivary_gland | 1.54202374 |
52 | MP0002234_abnormal_pharynx_morphology | 1.51083710 |
53 | MP0005646_abnormal_pituitary_gland | 1.51074795 |
54 | MP0008004_abnormal_stomach_pH | 1.49640727 |
55 | MP0008961_abnormal_basal_metabolism | 1.46133121 |
56 | MP0004947_skin_inflammation | 1.45056816 |
57 | MP0002876_abnormal_thyroid_physiology | 1.41985952 |
58 | MP0002928_abnormal_bile_duct | 1.41756035 |
59 | * MP0003953_abnormal_hormone_level | 1.31071089 |
60 | MP0002060_abnormal_skin_morphology | 1.29584340 |
61 | MP0003868_abnormal_feces_composition | 1.28600910 |
62 | * MP0005636_abnormal_mineral_homeostasis | 1.28407378 |
63 | MP0008789_abnormal_olfactory_epithelium | 1.27020378 |
64 | MP0005165_increased_susceptibility_to | 1.23004170 |
65 | MP0001270_distended_abdomen | 1.22872615 |
66 | MP0010771_integument_phenotype | 1.21936436 |
67 | MP0000627_abnormal_mammary_gland | 1.21409841 |
68 | MP0003705_abnormal_hypodermis_morpholog | 1.19328611 |
69 | MP0003941_abnormal_skin_development | 1.16029845 |
70 | MP0001984_abnormal_olfaction | 1.15642861 |
71 | MP0003252_abnormal_bile_duct | 1.15034965 |
72 | MP0003172_abnormal_lysosome_physiology | 1.14544144 |
73 | MP0000538_abnormal_urinary_bladder | 1.11689088 |
74 | MP0000377_abnormal_hair_follicle | 1.11056803 |
75 | MP0001986_abnormal_taste_sensitivity | 1.09994109 |
76 | MP0003122_maternal_imprinting | 1.09816988 |
77 | MP0005023_abnormal_wound_healing | 1.09097773 |
78 | MP0005365_abnormal_bile_salt | 1.05900043 |
79 | MP0005408_hypopigmentation | 1.04193386 |
80 | MP0005257_abnormal_intraocular_pressure | 1.01974319 |
81 | MP0005085_abnormal_gallbladder_physiolo | 1.01801026 |
82 | MP0000579_abnormal_nail_morphology | 1.01567271 |
83 | MP0004885_abnormal_endolymph | 1.00857023 |
84 | MP0003959_abnormal_lean_body | 1.00429771 |
85 | MP0005310_abnormal_salivary_gland | 1.00144323 |
86 | MP0010234_abnormal_vibrissa_follicle | 1.00072723 |
87 | MP0000685_abnormal_immune_system | 0.99356888 |
88 | MP0002009_preneoplasia | 0.95708292 |
89 | MP0005375_adipose_tissue_phenotype | 0.95267157 |
90 | MP0003119_abnormal_digestive_system | 0.94612658 |
91 | MP0005409_darkened_coat_color | 0.94219231 |
92 | MP0008995_early_reproductive_senescence | 0.93782070 |
93 | MP0005666_abnormal_adipose_tissue | 0.93700060 |
94 | MP0001849_ear_inflammation | 0.92677678 |
95 | MP0005387_immune_system_phenotype | 0.91673396 |
96 | MP0001790_abnormal_immune_system | 0.91673396 |
97 | MP0005377_hearing/vestibular/ear_phenot | 0.91542756 |
98 | MP0003878_abnormal_ear_physiology | 0.91542756 |
99 | MP0002139_abnormal_hepatobiliary_system | 0.91422348 |
100 | MP0000762_abnormal_tongue_morphology | 0.90424987 |
101 | MP0005535_abnormal_body_temperature | 0.90328048 |
102 | MP0000477_abnormal_intestine_morphology | 0.89698441 |
103 | MP0000858_altered_metastatic_potential | 0.88833921 |
104 | MP0009333_abnormal_splenocyte_physiolog | 0.86616684 |
105 | MP0002163_abnormal_gland_morphology | 0.86291933 |
106 | MP0003656_abnormal_erythrocyte_physiolo | 0.83975421 |
107 | * MP0000230_abnormal_systemic_arterial | 0.83453704 |
108 | MP0002098_abnormal_vibrissa_morphology | 0.83409194 |
109 | MP0001346_abnormal_lacrimal_gland | 0.83188246 |
110 | MP0001666_abnormal_nutrient_absorption | 0.83046771 |
111 | MP0002133_abnormal_respiratory_system | 0.82545541 |
112 | MP0005388_respiratory_system_phenotype | 0.82545541 |
113 | MP0005076_abnormal_cell_differentiation | 0.82313175 |
114 | MP0001879_abnormal_lymphatic_vessel | 0.81662187 |
115 | MP0005164_abnormal_response_to | 0.78555028 |
116 | MP0002166_altered_tumor_susceptibility | 0.78051088 |
117 | MP0009931_abnormal_skin_appearance | 0.77533801 |
118 | MP0005395_other_phenotype | 0.77303995 |
119 | MP0000631_abnormal_neuroendocrine_gland | 0.76738384 |
120 | MP0002168_other_aberrant_phenotype | 0.75689560 |
121 | MP0004185_abnormal_adipocyte_glucose | 0.75300796 |
122 | MP0003890_abnormal_embryonic-extraembry | 0.73480784 |
123 | MP0001661_extended_life_span | 0.72783641 |
124 | MP0005499_abnormal_olfactory_system | 0.72050941 |
125 | MP0005394_taste/olfaction_phenotype | 0.72050941 |
126 | MP0002118_abnormal_lipid_homeostasis | 0.71234748 |
127 | MP0003866_abnormal_defecation | 0.70770906 |
128 | MP0005166_decreased_susceptibility_to | 0.70768922 |
129 | MP0001664_abnormal_digestion | 0.69691929 |
130 | MP0005025_abnormal_response_to | 0.69572276 |
131 | MP0001873_stomach_inflammation | 0.69561288 |
132 | MP0009672_abnormal_birth_weight | 0.68664849 |
133 | MP0003795_abnormal_bone_structure | 0.67907959 |
134 | MP0002295_abnormal_pulmonary_circulatio | 0.67560854 |
135 | MP0005503_abnormal_tendon_morphology | 0.66163482 |
136 | MP0004883_abnormal_blood_vessel | 0.65408414 |
137 | MP0003638_abnormal_response/metabolism_ | 0.63929510 |
138 | MP0003045_fibrosis | 0.63210113 |
139 | MP0004019_abnormal_vitamin_homeostasis | 0.62707808 |
140 | MP0000367_abnormal_coat/_hair | 0.62148180 |
141 | MP0000639_abnormal_adrenal_gland | 0.62122587 |
142 | MP0003879_abnormal_hair_cell | 0.61139287 |
143 | MP0004272_abnormal_basement_membrane | 0.60073842 |
144 | * MP0009642_abnormal_blood_homeostasis | 0.59892941 |
145 | MP0005083_abnormal_biliary_tract | 0.59647317 |
146 | MP0000163_abnormal_cartilage_morphology | 0.58339524 |
147 | MP0002136_abnormal_kidney_physiology | 0.58120257 |
148 | MP0001502_abnormal_circadian_rhythm | 0.56367669 |
149 | MP0010368_abnormal_lymphatic_system | 0.55562278 |
150 | MP0005334_abnormal_fat_pad | 0.55473237 |
151 | MP0003566_abnormal_cell_adhesion | 0.54872687 |
152 | MP0005448_abnormal_energy_balance | 0.53966933 |
153 | MP0009703_decreased_birth_body | 0.53294657 |
154 | MP0004270_analgesia | 0.50504214 |
155 | MP0005332_abnormal_amino_acid | 0.49835677 |
156 | MP0008875_abnormal_xenobiotic_pharmacok | 0.48171787 |
157 | MP0005253_abnormal_eye_physiology | 0.46129547 |
158 | MP0001881_abnormal_mammary_gland | 0.42602532 |
159 | MP0001958_emphysema | 0.42005179 |
160 | MP0005670_abnormal_white_adipose | 0.41945632 |
161 | MP0005167_abnormal_blood-brain_barrier | 0.40910798 |
162 | MP0000470_abnormal_stomach_morphology | 0.40208277 |
163 | MP0001731_abnormal_postnatal_growth | 0.39883499 |
164 | MP0005367_renal/urinary_system_phenotyp | 0.36808811 |
165 | MP0000516_abnormal_urinary_system | 0.36808811 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormal respiratory epithelium morphology (HP:0012253) | 9.28372230 |
2 | Abnormal respiratory motile cilium morphology (HP:0005938) | 9.28372230 |
3 | Abnormal respiratory motile cilium physiology (HP:0012261) | 9.19807313 |
4 | Absent/shortened dynein arms (HP:0200106) | 9.12664265 |
5 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 9.12664265 |
6 | Abnormal ciliary motility (HP:0012262) | 8.92602594 |
7 | Rhinitis (HP:0012384) | 8.53181941 |
8 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.47188432 |
9 | Hypoglycemic seizures (HP:0002173) | 6.98059962 |
10 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.64418028 |
11 | * Bronchiectasis (HP:0002110) | 6.55083922 |
12 | Symptomatic seizures (HP:0011145) | 6.50662328 |
13 | Nasal polyposis (HP:0100582) | 6.37798291 |
14 | Hypoglycemic coma (HP:0001325) | 6.21416931 |
15 | Abnormality of the nasal mucosa (HP:0000433) | 5.67612210 |
16 | Hyperglycemia (HP:0003074) | 4.79626300 |
17 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.69630829 |
18 | Ketoacidosis (HP:0001993) | 4.53237961 |
19 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.39947931 |
20 | * Bronchitis (HP:0012387) | 4.35955632 |
21 | Abnormal pancreas size (HP:0012094) | 4.23490472 |
22 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.14551571 |
23 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.14551571 |
24 | Mucopolysacchariduria (HP:0008155) | 4.07127376 |
25 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.07127376 |
26 | Recurrent sinusitis (HP:0011108) | 3.96823059 |
27 | Late onset (HP:0003584) | 3.80701026 |
28 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.80079989 |
29 | Recurrent otitis media (HP:0000403) | 3.74741281 |
30 | Dysostosis multiplex (HP:0000943) | 3.71299200 |
31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.71027890 |
32 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.71027890 |
33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.71027890 |
34 | Large for gestational age (HP:0001520) | 3.67336380 |
35 | * Hypokalemia (HP:0002900) | 3.63710962 |
36 | Infertility (HP:0000789) | 3.55763551 |
37 | Chronic sinusitis (HP:0011109) | 3.53853705 |
38 | * Hyperactive renin-angiotensin system (HP:0000841) | 3.46068735 |
39 | Generalized aminoaciduria (HP:0002909) | 3.45332643 |
40 | Hyperparathyroidism (HP:0000843) | 3.39351439 |
41 | * Abnormality of renin-angiotensin system (HP:0000847) | 3.29914290 |
42 | Male infertility (HP:0003251) | 3.23396701 |
43 | Gout (HP:0001997) | 3.22484868 |
44 | Osteomalacia (HP:0002749) | 3.13549862 |
45 | * Abnormality of potassium homeostasis (HP:0011042) | 3.05316724 |
46 | * Decreased circulating renin level (HP:0003351) | 3.04589990 |
47 | Insulin resistance (HP:0000855) | 3.00698827 |
48 | * Abnormality of chloride homeostasis (HP:0011422) | 2.96141210 |
49 | Increased circulating renin level (HP:0000848) | 2.96103517 |
50 | Agitation (HP:0000713) | 2.95556847 |
51 | Conjugated hyperbilirubinemia (HP:0002908) | 2.88351604 |
52 | Hyperphosphatemia (HP:0002905) | 2.86460406 |
53 | Atelectasis (HP:0100750) | 2.80289691 |
54 | Flat acetabular roof (HP:0003180) | 2.78044935 |
55 | Tetany (HP:0001281) | 2.76813800 |
56 | Metabolic alkalosis (HP:0200114) | 2.74624506 |
57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.68858642 |
58 | * Hypokalemic alkalosis (HP:0001949) | 2.63592406 |
59 | Hypothermia (HP:0002045) | 2.60836137 |
60 | Lip pit (HP:0100267) | 2.60268985 |
61 | Chronic otitis media (HP:0000389) | 2.57321273 |
62 | * Hyperaldosteronism (HP:0000859) | 2.56064873 |
63 | Unilateral renal agenesis (HP:0000122) | 2.55282394 |
64 | Vacuolated lymphocytes (HP:0001922) | 2.54693413 |
65 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.49380984 |
66 | Ketosis (HP:0001946) | 2.49250714 |
67 | Tubulointerstitial nephritis (HP:0001970) | 2.48082387 |
68 | Cone-rod dystrophy (HP:0000548) | 2.39822510 |
69 | Exocrine pancreatic insufficiency (HP:0001738) | 2.36914185 |
70 | Intestinal atresia (HP:0011100) | 2.35962937 |
71 | Abnormality of purine metabolism (HP:0004352) | 2.33304594 |
72 | Retinal atrophy (HP:0001105) | 2.32762590 |
73 | Onycholysis (HP:0001806) | 2.32322763 |
74 | Abdominal distention (HP:0003270) | 2.31485179 |
75 | * Adrenal overactivity (HP:0002717) | 2.29381638 |
76 | * Renal salt wasting (HP:0000127) | 2.27997089 |
77 | Polyuria (HP:0000103) | 2.27607658 |
78 | Recurrent bronchitis (HP:0002837) | 2.25762900 |
79 | Thoracolumbar scoliosis (HP:0002944) | 2.25405778 |
80 | Prominent metopic ridge (HP:0005487) | 2.23787165 |
81 | Occipital encephalocele (HP:0002085) | 2.23345514 |
82 | Abnormal urine output (HP:0012590) | 2.22815358 |
83 | Goiter (HP:0000853) | 2.20829430 |
84 | Tachypnea (HP:0002789) | 2.20367571 |
85 | Right ventricular cardiomyopathy (HP:0011663) | 2.18094329 |
86 | Hypophosphatemia (HP:0002148) | 2.18073911 |
87 | Abnormality of renal excretion (HP:0011036) | 2.16919315 |
88 | Growth hormone excess (HP:0000845) | 2.16225783 |
89 | Progressive neurologic deterioration (HP:0002344) | 2.15171425 |
90 | Nuclear cataract (HP:0100018) | 2.14756464 |
91 | * Hyperkalemia (HP:0002153) | 2.14329430 |
92 | Absent eyebrow (HP:0002223) | 2.12943994 |
93 | Abnormal drinking behavior (HP:0030082) | 2.12150789 |
94 | Polydipsia (HP:0001959) | 2.12150789 |
95 | Hypomagnesemia (HP:0002917) | 2.09875099 |
96 | Protuberant abdomen (HP:0001538) | 2.05677442 |
97 | * Hypotension (HP:0002615) | 2.05587365 |
98 | Pili torti (HP:0003777) | 2.05127900 |
99 | Hypercortisolism (HP:0001578) | 2.04477286 |
100 | Limb hypertonia (HP:0002509) | 2.02859187 |
101 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.02103745 |
102 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.00101307 |
103 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 10.6236054 |
104 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.99907636 |
105 | Hypoplasia of the fovea (HP:0007750) | 1.99907636 |
106 | Dysautonomia (HP:0002459) | 1.97570574 |
107 | Increased IgE level (HP:0003212) | 1.97239206 |
108 | * Hyponatremia (HP:0002902) | 1.95580437 |
109 | Interstitial pulmonary disease (HP:0006530) | 1.95462505 |
110 | Abnormality of magnesium homeostasis (HP:0004921) | 1.95105699 |
111 | Hyperphosphaturia (HP:0003109) | 1.94005600 |
112 | Congenital glaucoma (HP:0001087) | 1.93631728 |
113 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.92803440 |
114 | Abnormality of the dental pulp (HP:0006479) | 1.90432138 |
115 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.88997357 |
116 | Abnormality of nail color (HP:0100643) | 1.87054197 |
117 | Abnormal biliary tract morphology (HP:0012440) | 1.84541981 |
118 | Abnormality of the metopic suture (HP:0005556) | 1.83595905 |
119 | Glycosuria (HP:0003076) | 1.82488196 |
120 | Abnormality of urine glucose concentration (HP:0011016) | 1.82488196 |
121 | Distal lower limb muscle weakness (HP:0009053) | 1.81154425 |
122 | Hypoplastic labia majora (HP:0000059) | 1.80721510 |
123 | * Chronic bronchitis (HP:0004469) | 1.80207452 |
124 | Congenital sensorineural hearing impairment (HP:0008527) | 1.79819680 |
125 | Thin bony cortex (HP:0002753) | 1.78970714 |
126 | Abnormality of the dental root (HP:0006486) | 1.78696728 |
127 | Taurodontia (HP:0000679) | 1.78696728 |
128 | Abnormality of permanent molar morphology (HP:0011071) | 1.78696728 |
129 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.78618425 |
130 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.78618425 |
131 | Abnormality of glycolipid metabolism (HP:0010969) | 1.78618425 |
132 | Disproportionate short-trunk short stature (HP:0003521) | 1.78535504 |
133 | Cystic liver disease (HP:0006706) | 1.76831773 |
134 | Bell-shaped thorax (HP:0001591) | 1.75414793 |
135 | Restlessness (HP:0000711) | 1.74922910 |
136 | Abnormality of the fovea (HP:0000493) | 1.74324657 |
137 | Erythema (HP:0010783) | 1.72838362 |
138 | Hypotrichosis (HP:0001006) | 1.72412967 |
139 | Villous atrophy (HP:0011473) | 1.72298248 |
140 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.72298248 |
141 | Pheochromocytoma (HP:0002666) | 1.72088543 |
142 | Menstrual irregularities (HP:0000858) | 1.71047528 |
143 | Plantar hyperkeratosis (HP:0007556) | 1.70420455 |
144 | Abnormality of the common coagulation pathway (HP:0010990) | 1.70331369 |
145 | Elevated alkaline phosphatase (HP:0003155) | 1.70082783 |
146 | True hermaphroditism (HP:0010459) | 1.69965095 |
147 | Abnormality of molar (HP:0011077) | 1.64732808 |
148 | Abnormality of molar morphology (HP:0011070) | 1.64732808 |
149 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.63740602 |
150 | Chronic hepatic failure (HP:0100626) | 1.62331408 |
151 | * Abnormality of sodium homeostasis (HP:0010931) | 1.61644555 |
152 | Pancreatic fibrosis (HP:0100732) | 1.59092474 |
153 | Popliteal pterygium (HP:0009756) | 1.56862047 |
154 | Acanthosis nigricans (HP:0000956) | 1.55561723 |
155 | Tubulointerstitial fibrosis (HP:0005576) | 1.55245248 |
156 | Palmoplantar hyperkeratosis (HP:0000972) | 1.54771601 |
157 | Tubular atrophy (HP:0000092) | 1.54293019 |
158 | Abnormality of the salivary glands (HP:0010286) | 1.54232685 |
159 | Abnormal hair laboratory examination (HP:0003328) | 1.53441418 |
160 | Spinal cord compression (HP:0002176) | 1.49648003 |
161 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.49507206 |
162 | Absent frontal sinuses (HP:0002688) | 1.48456976 |
163 | Furrowed tongue (HP:0000221) | 1.47945326 |
164 | Flattened epiphyses (HP:0003071) | 1.45831306 |
165 | * Dehydration (HP:0001944) | 1.42276310 |
166 | Glucose intolerance (HP:0000833) | 1.39474212 |
167 | Palmar hyperkeratosis (HP:0010765) | 1.38580284 |
168 | Corneal erosion (HP:0200020) | 1.38076491 |
169 | * Alkalosis (HP:0001948) | 1.35064833 |
170 | Bifid scrotum (HP:0000048) | 1.34231746 |
171 | Malnutrition (HP:0004395) | 1.33304362 |
172 | Neonatal short-limb short stature (HP:0008921) | 1.32862680 |
173 | Hemorrhage of the eye (HP:0011885) | 1.32134461 |
174 | Alopecia of scalp (HP:0002293) | 1.31684414 |
175 | Nephritis (HP:0000123) | 1.30057629 |
176 | Ventricular fibrillation (HP:0001663) | 1.29757085 |
177 | Tubulointerstitial abnormality (HP:0001969) | 1.29341488 |
178 | * Nephropathy (HP:0000112) | 1.29048617 |
179 | Short thorax (HP:0010306) | 1.27751504 |
180 | Ridged nail (HP:0001807) | 1.27469032 |
181 | Vascular calcification (HP:0004934) | 1.27386155 |
182 | Short femoral neck (HP:0100864) | 1.26729502 |
183 | Postaxial foot polydactyly (HP:0001830) | 1.22600977 |
184 | Woolly hair (HP:0002224) | 1.22563163 |
185 | Obstructive sleep apnea (HP:0002870) | 1.22280122 |
186 | Intrahepatic cholestasis (HP:0001406) | 1.22058535 |
Rank | Gene Set | Z-score |
---|---|---|
1 | INSRR | 6.69334988 |
2 | PASK | 5.67877879 |
3 | MAPK15 | 4.24285341 |
4 | MAP3K2 | 3.68942204 |
5 | MST4 | 3.66115727 |
6 | MAPKAPK3 | 3.48126938 |
7 | TAOK3 | 3.17110838 |
8 | MST1R | 3.13713826 |
9 | ERN1 | 3.05712835 |
10 | FRK | 3.03124710 |
11 | HIPK2 | 2.94600925 |
12 | WNK4 | 2.83131639 |
13 | EEF2K | 2.57717863 |
14 | PRKD3 | 2.48770581 |
15 | IRAK3 | 2.48173861 |
16 | SMG1 | 2.37407865 |
17 | STK24 | 2.16097391 |
18 | WNK3 | 1.99656568 |
19 | FLT3 | 1.93849437 |
20 | MAP3K3 | 1.89470438 |
21 | AKT3 | 1.85497454 |
22 | MAP3K1 | 1.79935885 |
23 | PRPF4B | 1.69586081 |
24 | NME1 | 1.68574187 |
25 | NTRK1 | 1.66500151 |
26 | PDGFRA | 1.65760861 |
27 | EPHA3 | 1.60539041 |
28 | IRAK1 | 1.54214657 |
29 | LRRK2 | 1.41447881 |
30 | PTK2 | 1.33684864 |
31 | PKN2 | 1.30197297 |
32 | PTK6 | 1.27306077 |
33 | TRIB3 | 1.22552267 |
34 | TBK1 | 1.20525246 |
35 | MET | 1.19614041 |
36 | SCYL2 | 1.18953376 |
37 | TIE1 | 1.09894552 |
38 | MAP2K2 | 1.08270615 |
39 | RPS6KB2 | 1.07101927 |
40 | UHMK1 | 1.06318875 |
41 | FER | 1.04760729 |
42 | CAMKK2 | 1.04443270 |
43 | CDC42BPA | 1.03668006 |
44 | TRPM7 | 1.01841984 |
45 | IRAK2 | 0.99872665 |
46 | MAP3K13 | 0.98929126 |
47 | PRKCH | 0.97680494 |
48 | PIK3CG | 0.96907783 |
49 | DYRK1B | 0.92051740 |
50 | EIF2AK3 | 0.91416142 |
51 | GRK6 | 0.91399351 |
52 | ICK | 0.87397665 |
53 | PAK3 | 0.85969966 |
54 | EPHB1 | 0.85052048 |
55 | SIK1 | 0.84748105 |
56 | MAP3K7 | 0.83301389 |
57 | NLK | 0.82458798 |
58 | STK10 | 0.81033016 |
59 | STK38 | 0.80495619 |
60 | TESK1 | 0.80235847 |
61 | EPHA2 | 0.78293848 |
62 | PAK4 | 0.77449120 |
63 | PIK3CA | 0.77425376 |
64 | RPS6KA2 | 0.76826936 |
65 | ZAP70 | 0.76385654 |
66 | FGFR4 | 0.76357619 |
67 | BCKDK | 0.75990783 |
68 | NTRK3 | 0.75107088 |
69 | PRKD2 | 0.74003685 |
70 | LMTK2 | 0.71078886 |
71 | STK39 | 0.69955086 |
72 | PRKAA2 | 0.69527075 |
73 | TAOK1 | 0.67531284 |
74 | PRKCI | 0.67241976 |
75 | ERBB3 | 0.66984908 |
76 | LATS1 | 0.66665585 |
77 | MAP3K6 | 0.65206213 |
78 | RET | 0.63311192 |
79 | SGK494 | 0.62137078 |
80 | SGK223 | 0.62137078 |
81 | TYK2 | 0.60465210 |
82 | STK38L | 0.59933129 |
83 | MAP2K6 | 0.59706983 |
84 | PRKCE | 0.58886396 |
85 | WNK1 | 0.58618094 |
86 | IRAK4 | 0.56710555 |
87 | YES1 | 0.55089485 |
88 | TGFBR2 | 0.54194928 |
89 | SIK3 | 0.53246379 |
90 | JAK2 | 0.52874324 |
91 | SGK2 | 0.52804191 |
92 | PRKCD | 0.51969674 |
93 | PRKG2 | 0.51412309 |
94 | ARAF | 0.50793208 |
95 | TTK | 0.47708657 |
96 | IKBKE | 0.47527913 |
97 | RIPK4 | 0.46856326 |
98 | MAPKAPK5 | 0.46206043 |
99 | ITK | 0.45906552 |
100 | ERBB2 | 0.45344477 |
101 | BRAF | 0.45137708 |
102 | PDGFRB | 0.44726836 |
103 | NEK6 | 0.44577143 |
104 | CHUK | 0.44512733 |
105 | GSK3A | 0.44469184 |
106 | SGK3 | 0.43914479 |
107 | BRSK2 | 0.43133730 |
108 | FGFR3 | 0.42034765 |
109 | PRKD1 | 0.41440213 |
110 | PIM2 | 0.39637606 |
111 | PTK2B | 0.38811955 |
112 | BMPR1B | 0.36163359 |
113 | JAK1 | 0.35353029 |
114 | MAP3K14 | 0.34924045 |
115 | ADRBK1 | 0.34017125 |
116 | MAP2K1 | 0.33056419 |
117 | PRKAA1 | 0.33039075 |
118 | JAK3 | 0.31941470 |
119 | IGF1R | 0.31873307 |
120 | CSNK1A1 | 0.31749795 |
121 | PDK1 | 0.29513252 |
122 | RIPK1 | 0.29260573 |
123 | CDK12 | 0.28376687 |
124 | MAPKAPK2 | 0.27644551 |
125 | BLK | 0.27400328 |
126 | PRKACG | 0.27264838 |
127 | BCR | 0.25865426 |
128 | MTOR | 0.25339561 |
129 | MYLK | 0.25085958 |
130 | CSK | 0.25017218 |
131 | MELK | 0.24688425 |
132 | CDK6 | 0.24304100 |
133 | MAP3K12 | 0.23918663 |
134 | TEC | 0.23747325 |
135 | KSR2 | 0.23574514 |
136 | CAMK2D | 0.22874170 |
137 | GRK1 | 0.22225442 |
138 | PRKACA | 0.22218741 |
139 | MARK2 | 0.22157425 |
140 | SRC | 0.21873013 |
141 | OXSR1 | 0.21501187 |
142 | CAMK1G | 0.21135812 |
143 | TGFBR1 | 0.16879164 |
144 | MAP3K10 | 0.16777692 |
145 | MAP2K3 | 0.16750376 |
146 | PDPK1 | 0.16275403 |
147 | RPS6KB1 | 0.15802051 |
148 | BMPR2 | 0.14531357 |
149 | PRKCA | 0.12583884 |
150 | SGK1 | 0.10556261 |
151 | MAPK3 | 0.10541938 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 9.02404114 |
2 | Protein export_Homo sapiens_hsa03060 | 5.18849883 |
3 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.75766854 |
4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.69148255 |
5 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.58282018 |
6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.23663172 |
7 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.02744042 |
8 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.92231784 |
9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.89057675 |
10 | Insulin secretion_Homo sapiens_hsa04911 | 2.87070289 |
11 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.51208240 |
12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.41404788 |
13 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.02085496 |
14 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.94874675 |
15 | Lysosome_Homo sapiens_hsa04142 | 1.90508062 |
16 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.90225981 |
17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.87917045 |
18 | Retinol metabolism_Homo sapiens_hsa00830 | 1.85665320 |
19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.80642083 |
20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.79156876 |
21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.76728261 |
22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.75131535 |
23 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.71416770 |
24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.64949013 |
25 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.55079083 |
26 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.49091699 |
27 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.45583572 |
28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.44867140 |
29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.42684611 |
30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.37770043 |
31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.37121860 |
32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.32844771 |
33 | Tight junction_Homo sapiens_hsa04530 | 1.26277058 |
34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25301072 |
35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24945471 |
36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.24479122 |
37 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.22951674 |
38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19925495 |
39 | Hepatitis C_Homo sapiens_hsa05160 | 1.18245341 |
40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17623109 |
41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.17555375 |
42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.17418716 |
43 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.16423870 |
44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.12020142 |
45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08250765 |
46 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.06798442 |
47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.05588524 |
48 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.02029186 |
49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01837478 |
50 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.01706442 |
51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.97895330 |
52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97186661 |
53 | Insulin resistance_Homo sapiens_hsa04931 | 0.95625797 |
54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94570209 |
55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93628583 |
56 | ABC transporters_Homo sapiens_hsa02010 | 0.90988138 |
57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90538804 |
58 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.89234391 |
59 | Galactose metabolism_Homo sapiens_hsa00052 | 0.88615538 |
60 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84481279 |
61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83352255 |
62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82347458 |
63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82334174 |
64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81629652 |
65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80295218 |
66 | * Taste transduction_Homo sapiens_hsa04742 | 0.79413472 |
67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77513266 |
68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76637851 |
69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.74887971 |
70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73021084 |
71 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72947528 |
72 | Salivary secretion_Homo sapiens_hsa04970 | 0.72432632 |
73 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.69759047 |
74 | Prion diseases_Homo sapiens_hsa05020 | 0.66022748 |
75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61831140 |
76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60758307 |
77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60293332 |
78 | Mineral absorption_Homo sapiens_hsa04978 | 0.60035162 |
79 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58984054 |
80 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55613145 |
81 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.54874496 |
82 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54592396 |
83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54367473 |
84 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52274657 |
85 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51642309 |
86 | Circadian entrainment_Homo sapiens_hsa04713 | 0.50406401 |
87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50066763 |
88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.49514517 |
89 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49233512 |
90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49206341 |
91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48613577 |
92 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47269468 |
93 | Endocytosis_Homo sapiens_hsa04144 | 0.47180160 |
94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46960351 |
95 | Renin secretion_Homo sapiens_hsa04924 | 0.45453551 |
96 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45146077 |
97 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44253851 |
98 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43374791 |
99 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42871918 |
100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42717830 |
101 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.42309621 |
102 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41506208 |
103 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40827099 |
104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40759526 |
105 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.39510437 |
106 | Phagosome_Homo sapiens_hsa04145 | 0.39429068 |
107 | Influenza A_Homo sapiens_hsa05164 | 0.39162704 |
108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37858339 |
109 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37592404 |
110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37545002 |
111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.36624915 |
112 | Amoebiasis_Homo sapiens_hsa05146 | 0.35359118 |
113 | Pertussis_Homo sapiens_hsa05133 | 0.35019384 |
114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34938021 |
115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34659833 |
116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34524133 |
117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34130026 |
118 | Bladder cancer_Homo sapiens_hsa05219 | 0.34025578 |
119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.33468663 |
120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33372535 |
121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32321629 |
122 | Allograft rejection_Homo sapiens_hsa05330 | 0.32198047 |
123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32104056 |
124 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.31251340 |
125 | Alcoholism_Homo sapiens_hsa05034 | 0.30737982 |
126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30278817 |
127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29693364 |
128 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29011857 |
129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28702389 |
130 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.28289984 |
131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.28253633 |
132 | Apoptosis_Homo sapiens_hsa04210 | 0.28033582 |
133 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27781549 |
134 | Bile secretion_Homo sapiens_hsa04976 | 0.27361374 |
135 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26942114 |
136 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26570927 |
137 | Lysine degradation_Homo sapiens_hsa00310 | 0.26283603 |
138 | GABAergic synapse_Homo sapiens_hsa04727 | 0.25931397 |
139 | Peroxisome_Homo sapiens_hsa04146 | 0.25448563 |
140 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.25116641 |
141 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.24666425 |
142 | Prostate cancer_Homo sapiens_hsa05215 | 0.24626960 |
143 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.24249896 |
144 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23357988 |
145 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.23040674 |
146 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.22450333 |
147 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.20141803 |
148 | Adherens junction_Homo sapiens_hsa04520 | 0.20057523 |
149 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.19918899 |
150 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18428502 |
151 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.17863265 |
152 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.17789445 |
153 | Melanogenesis_Homo sapiens_hsa04916 | 0.15345791 |
154 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15105557 |
155 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14747584 |
156 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.14448340 |
157 | Endometrial cancer_Homo sapiens_hsa05213 | 0.13883737 |
158 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.13557671 |
159 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.12971611 |